IEU Seminar: Professor Sun Ha Jee, Graduate School of Public Health, Yonsei University
MRC INTEGRATIVE EPIDEMIOLOGY UNIT (IEU)
Friday, 10th November, 2017 : 10.00 – 11.00
Room OS6, Second Floor, Oakfield House
Sun Ha Jee
Professor of Epidemiology and Health Promotion
Graduate School of Public Health, Yonsei University
Epidemiologic findings from Korean Cancer Prevention Study-II
The Korean Cancer Prevention Study-II (KCPS-II) Biobank is a large blood-based cohort study with long term follow-up via a unique linkage of routine, nationwide medical examinations conducted at health promotion centres across South Korea with records for mortality and hospitalization. Recruitment was through eighteen health promotion centres across South Korea, starting in 2004, with 90% of participants recruited between mid-2005 and the end of 2008. The study comprises 156,701 adults (94 840 men and 61 861 women). Mean age at recruitment was 42 years. KCPS-II Biobank data, or subsets of the data, have already been used in several epidemiological and genetic studies, and have contributed to international collaborative research projects. These studies have shown that genetic variants in CDH13 influence adiponectin levels in Korean adults and that serum adiponectin is associated with a family history of diabetes independently of obesity and insulin resistance.
Sun Ha Jee, PhD, MPH, is a professor of Epidemiology and Health Promotion, Graduate School of Public Health, Yonsei University, where he teaches epidemiology. He obtained his Ph.D. degree in public health from Yonsei University in 1993 and has performed postdoctoral studies from the Bloomberg School of Public Health, Johns Hopkins University in 1995-1997. His current research focuses on a large scaled prospective cohort study for smoking, obesity, metabolic syndrome, and cancer. He developed the Korean Cancer Prevention Study (KCPS) in 2001. This is a large-scale cohort study of active and passive smoking and risk for cancer and other diseases among the Korean population. The cohort consists of over one million Korean adults who had a physical examination as part of their care by the national health insurance program. Recent analyses have addressed 1) diabetes, blood glucose, and cancer risk; 2) white blood cells and risk for cancer and cardiovascular disease and; 3) body mass index and risk for mortality and morbidity. He is also a principal investigator of the KCPS-II Biobank with 156,701 blood specimens funded by Seoul City in 2005-2010..